Close

Ratings by Craig-Hallum (Matt Hewitt)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/29/2024 Science 37 SNCE Downgrade Hold
(Buy)
4.74
(5.71)
20.46% Details
1/19/2024 Schrodinger SDGR Maintain Buy
(N/A)
 
 
  Details
1/4/2024 Agiliti Inc AGTI New Coverage Buy
(N/A)
7.37
(7.42)
0.68% Details
11/29/2023 MaxCyte Inc. MXCT New Coverage Buy
(N/A)
4.68
(4.52)
-3.42% Details
11/10/2023 BioLife Solutions BLFS Maintain Buy
(N/A)
 
 
  Details
11/2/2023 Schrodinger SDGR Maintain Buy
(N/A)
 
 
  Details
7/11/2023 BioLife Solutions BLFS New Coverage Buy
(N/A)
21.29
(17.70)
-16.86% Details
4/13/2023 OmniAb, Inc. OABI New Coverage Buy
(N/A)
3.81
(5.54)
45.41% Details
11/4/2022 Schrodinger SDGR Maintain Buy
(N/A)
 
 
  Details
5/24/2022 CynergisTek CTEK Downgrade Hold
(Buy)
0.59
(1.25)
111.86% Details
5/17/2022 CynergisTek CTEK Maintain Buy
(N/A)
 
 
  Details
10/4/2021 Schrodinger SDGR Maintain Buy
(N/A)
 
 
  Details
9/28/2021 Surgalign Holdings Inc SRGA Downgrade Hold
(Buy)
1.23
(0.18)
-85.37% Details
8/9/2021 Surgalign Holdings Inc SRGA Maintain Buy
(N/A)
 
 
  Details
4/30/2021 Omnicell OMCL Maintain Buy
(N/A)
 
 
  Details
1/14/2021 Omnicell OMCL Maintain Buy
(N/A)
 
 
  Details
1/4/2021 Recro Pharma REPH New Coverage Buy
(N/A)
2.85
(2.09)
-26.67% Details
10/28/2020 Omnicell OMCL Maintain Buy
(N/A)
 
 
  Details
8/14/2020 CynergisTek CTEK Maintain Buy
(N/A)
 
 
  Details
7/29/2020 Omnicell OMCL Maintain Buy
(N/A)
 
 
  Details
2/21/2020 Repligen RGEN Maintain Buy
(N/A)
 
 
  Details
10/4/2019 AngioDynamics ANGO Maintain Hold
(N/A)
 
 
  Details
8/15/2019 CynergisTek CTEK Maintain Buy
(N/A)
 
 
  Details
8/5/2019 Repligen RGEN Maintain Buy
(N/A)
 
 
  Details
7/26/2019 Omnicell OMCL Upgrade Buy
(Hold)
70.67
(26.33)
-62.74% Details
4/26/2019 Omnicell OMCL Downgrade Hold
(Buy)
77.45
(70.67)
-8.75% Details
9/17/2018 Omnicell OMCL Maintain Buy
(Buy)
 
 
  Details